Scientific Publications: 2000-2002

Kerney DL. Assessing Self-Reported Use of Allergy Medications and Their Impact on Symptoms. Presented at Drug Information Association 4th Annual Workshop on Pharmaceutical Outcomes Research, Newport, RI, October 2002.

Kerney D. Real-World Treatment with Desloratadine in Seasonal Allergic Rhinitis (SAR) Patients. Presented at the American College of Allergy, Asthma & Immunology, Annual Meeting, San Antonio, TX, Spring 2002.

Graham JP, Kerney D, LeVine P. Assessment of Standard Medical Care in Patients with Type 2 Diabetes Mellitus. Diabetes 2002;51(suppl. 2):A-274. Presented at the American Diabetes Association, 62nd Scientific Sessions, San Francisco, CA, June 2002.

Kerney D, LeVine P, Wright R, Graham J. Is Control of Hemoglobin A1C Levels Associated with Control of Other Cardiovascular Parameters Important For Patients with Type 2 Diabetes Mellitus? Diabetes 2002;51(suppl. 2):A-274. Presented at the American Diabetes Association, 62nd Scientific Sessions, San Francisco, CA, June 2002.

Graham JP, Kovalick L, Kerney D. Control of Important Clinical Parameters for Patients with Type 2 Diabetes Mellitus. Diabetes 2002;51(suppl. 2):A-274. Presented at the American Diabetes Association, 62nd Scientific Sessions, San Francisco, CA, June 2002.

Peterson C, Lane J, Hu H, et al; on behalf of the US Migraine Study Protocol Investigators. Migraine Treatment with Rizatriptan-Effects on Work Loss in Naturalistic Setting. Presented at the American Academy of Neurology, 53rd Annual Meeting, Philadelphia, PA, May 2001.

Hu H, Raskin N, Cowan R, et al.; on behalf of the US Migraine Study Protocol Investigators. Migraine Attack Treatment with Rizatriptan-Timing of Medication Use and Clinical Outcomes. Presented at the American Academy of Neurology, 52nd Annual Meeting, San Diego, CA, May 2000.

Cutrer FM, Jamieson D, Hu H, et al.; on behalf of the US Migraine Study Protocol Investigators. Effectiveness of Different Oral Formulations of Rizatriptan in Treating Migraine in Naturalistic Setting. Presented at the American Headache Society, 42nd Annual Meeting, Montreal, Quebec, June 2000.

Landy S, Mauskop A, Hu H, et al.; on behalf of the US Migraine Study Protocol Investigators. Real World Experiences in Migraine Treatment with Rizatriptan in Patients Previously Treated by Other Oral Triptans. Presented at the American Headache Society, 42nd Annual Meeting, Montreal, Quebec, June 2000.

Solomon S, Frishberg, B Hu XH, et al.; on behalf of the US Migraine Study Protocol Investigators. Improved Migraine Treatment Outcomes with Rizatriptan in Triptan-Naïve Patients: A Naturalistic Study. Presented at the American Headache Society, 42nd Annual Meeting, Montreal, Quebec, June 2000.

Hu XH, Raskin NH, Cowan R, et al.; on behalf of the United States Migraine Study Protocol (USMAP) Investigators. Treatment of migraine with rizatriptan: when to take the medication. Headache: The Journal of Head and Face Pain. 2002;42(1):16-20.

Solomon S, Frishberg, B Hu XH, et al. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study. Clinical Therapeutics. 2001;23(6):886-900.

Scientific Publications: 2009-2010

Scientific Publications: 2006-2008

Scientific Publications: 2003-2005

Scientific Publications: Full List

Scientific Publications PDF